Mon, 07 Dec 2015 13:00:00 GMT ~ Acology Releases Prelim Results of Clinical Trials
[Marketwired] - Acology Inc. announced today that preliminary results from 90 day clinical trials in the hospice and palliative care industries are very positive, with care givers reporting that its signature product, ...
Tue, 01 Dec 2015 13:00:00 GMT ~ Letter to Shareholders
[Marketwired] - Acology Inc. announced today that the calendar year-end will exceed its previously announced sales numbers for its signature product, The MedTainer™. Management declares that the company has progressed ...
Wed, 18 Nov 2015 13:00:00 GMT ~ Acology: One Product, Two Growing Markets
[Marketwired] - Acology Inc. has just returned from the National Re-Admission Prevention Collaborative conference held at Good Samaritan Hospital in Los Angeles and reports extremely positive interest and feedback in ...
Link: http://www.otcmarkets.com/stock/ACOL/company-info Ticker: $ACOL OTC Market Place: OTC Pink Current CIK code: 0001096950 Company name: Acology Inc. Company website: http://www.acologyinc.com Incorporated In: FL, USA
Business Description: Acology, Inc. represents itself as a innovative company operating in the fields of manufacturing, branding, sales, consulting and has most recently brought a revolutionary design to the forefront, the first-ever polypropylene (PP) air-tight, water-tight , smell-proof delivery and storage system which also embodies a grinding component. Acology Containers give consumers the ability to store, carry, and dispense items such as pharmaceuticals, herbal remedies, teas and many other solid and/or liquid contents with ease.Less >>
$ACOL share structure
## source: otcmarkets.com
Market Value: $7,461,932 a/o Dec 15, 2015 Shares Outstanding: 4,974,621,214 a/o Nov 11, 2015 Float: 700,049,785 a/o Apr 15, 2015 Authorized Shares: 6,000,000,000 a/o Apr 23, 2015 Par Value: 0.00001
$ACOL extra dd links
Company name: Acology Inc. Company website: http://www.acologyinc.com
QUOTE from shareholder letter DECEMBER 1st - Projected sales at the end of calendar 2015, previously projected conservatively at $1.3M are now expected to surpass $1.5M in gross sales while at the same time reducing costs and increasing margins.
Produces and sells the first-ever polypropylene (PP) air-tight, water-tight , smell-proof delivery and storage system which also embodies a grinding component. Acology Containers give consumers the ability to store, carry, and dispense items such as pharmaceuticals, herbal remedies, teas and many other solid and/or liquid contents with ease.
Letter to Shareholders CORONA, CA -- (Marketwired) -- 12/01/15 -- Acology Inc. (OTC PINK: ACOL) announced today that the calendar year-end will exceed its previously announced sales numbers for its signature product, The MedTainer™. Management declares that the company has progressed in 2015 to the point where more sales associates will be hired to meet the growing demand for the product. It is also projected that by April of 2016 the number of MedTainers distributed within a 30-day cycle will exceeded 75,000 and continue to grow exponentially by mid-summer to 100,000. Projected sales at the end of calendar 2015, previously projected conservatively at $1.3M are now expected to surpass $1.5M in gross sales while at the same time reducing costs and increasing margins. At the beginning of September 2015 Acology found itself in the unique position of having a single, stand-alone product serving two distinct markets. Acology sales executives had begun to open the geritriac, hospice and palliative care industries and have added 3 distinguished professionals in that field to its Advisory Board. These included 2 of the most well-known executives in the administration of Hospitals, Skilled Nursing Facilities and transitional home-care and one of the premiere geriatricians in the United States. In concert they have introduced Acology to the rapidly-growing medical equipment and skilled-nursing fields and Acology products are now in clinical trials within these industries. Acology approaches the close of calendar 2015 with the certain knowledge that demand for their signature product, The MedTainer, will continue to increase domestically and globally. It has successfully defended intellectual property incursions into its business space and challenged counterfeit products. The original 45 distributors that Acology held in October of 2014 has grown to over 900 domestic and international distributors, wholesalers, merchants and brokers. The original physical 5200 sq.ft. sales and distribution center in Corona is expanding an additional 5,000 sq. ft. by the beginning of 2016. New business, in the areas already described but especially in the medical industry, will continue to develop and grow exponentially as demand for the Medtainer increases. Safe Harbor Statement
Acology Inc. and D&C Distributors are located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880. Acology trades on the OTC under the call letters ACOL. The company's email is www.Acologyinc.com. Please send inquiries toinfo@acologyinc.com or call (844) ACOLOGY (844-226-5649). Contact: Acology Inc. info@acologyinc.com Source: Acology Inc.
$ACOL EXPONENTIAL GROWTH!!!
SALES for $ACOL blowing up!
Compare: Q2’14 to Q2’15 up 322% from $168,547 to $712,672! Q3’14 to Q3’15 up 294% from $264,312 to $1,041,375!!!
In fact by Q2’15, ACOL has beaten FULL YEAR 2014 sales by 119%! Q3’15 BEAT last years FULL YEAR SALES by a whopping 345%!!!
GROSS PROFIT EXPLODING!!!
Compare: Q2’14 to Q2’15 up 328% from $112,088 to $480,058! Q3’14 to Q3’15 up 280% from $178,734 to $679,214!!!
By the end of Q2’15, Gross Profit beat FULL YEAR 2014 G.P. by 116%! By the end of Q3’15 ACOL BEAT FY’14 Gross Profit by 331%!!!
Then on Dec 1st, Acology Inc. puts out a shareholder newsletter stating that earlier sales projections need to be INCREASED!!! That the original 45 distribution points have erupted to over 900! And facilities are DOUBLING in square footage! Plus, they added 3 new distinguished professionals to their Advisory Board!
“New business, in the areas already described but especially in the medical industry, will continue to develop and grow exponentially as demand for the Medtainer increases” -12/01/15 Shareholder Letter